FDA approves treatment for inhalation anthrax

The U.S. Food and Drug Administration today approved Anthrasil, Anthrax Immune Globulin Intravenous (Human), to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm439752.htm

Source: Food and Drug Administration - March 25, 2015 Category: American Health Source Type: news

More News: American Health | Anthrax | Food and Drug Administration (FDA) | Gammagard Liquid | Privigen